再获亿元融资！美创医疗半年连融两轮

Group 1 - The core viewpoint of the article highlights the successful financing round of Suzhou Meichuang Medical Technology Co., Ltd., which raised over 200 million yuan in total funding within six months to accelerate clinical transformation and commercialization of its core products [1][3] - Meichuang Medical, founded in 2021, focuses on innovative medical devices for peripheral vascular and tumor intervention, aiming to develop products suitable for Chinese patients [3] - The company has achieved mass production of medical-grade ePTFE (expanded polytetrafluoroethylene) materials, becoming the first domestic enterprise to overcome this critical technology, and has completed NMPA documentation for its ePTFE products [3] Group 2 - Upcoming events organized by the company include the Second Global Medical Technology Conference on July 17, 2025, and the Third Global Surgical Robot Conference on September 4-5, 2025 [1][4] - The recent financing involved investors such as Suzhou Venture Capital, Paradise Silicon Valley, Guanghua Wutong, and Medpark, with Kai Cheng Capital serving as the exclusive financial advisor [1]